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MULTIPHASE MODELING OF TUMOR GROWTH WITH MATRIX
REMODELING AND FIBROSIS
ANDREA TOSIN AND LUIGI PREZIOSI
Abstract. We present a multiphase mathematical model for tumor growth which incor-
porates the remodeling of the extracellular matrix and describes the formation of fibrotic
tissue by tumor cells. We also detail a full qualitative analysis of the spatially homogeneous
problem, and study the equilibria of the system in order to characterize the conditions
under which fibrosis may occur.
1. Introduction
It is well known that tumor tissues are often stiffer than normal tissues. For instance, a
normal mammary gland has an elastic modulus of about 2 hPa, which may dramatically
increase for a breast tumor up to about 4 kPa [1]. For this reason self-palpation is often
a successful tool of pre-diagnosis for the detection of possible stiffer nodules, therefore
so encouraged. In most cases, the increased stiffness is due to the presence of a denser
and more fibrous stroma [2, 3, 4] coming from a considerable change in the content of
ExtraCellular Matrix (ECM). Indeed, as reported in [1], doubling the percent amount of
collagen would increase the stiffness of a tissue by almost one order of magnitude (328 Pa
and 1589 Pa for a 2 mg/ml and a 4 mg/ml collagen mixture, respectively). The percentage
of ECM also changes within the same tumor type during tumor progression [5].
The continuous remodeling of ECM is a physiologically functional process, because it
allows to keep the stroma young and reactive. In fact, prolonged rest is detrimental for
bones and muscles, while physical training has an opposite effect. The ECM is constantly
renewed through the concomitant production of Matrix MetalloProteinases (MMPs) and
new ECM components. In stationary conditions, remodeling of ECM is a slow process: for
instance, in human lungs the physiological turnover of ECM is 10 to 15% per day [6], which
leads to an estimated complete turnover in a period of nearly one week. However, when a
new tissue has to be formed, e.g. to heal a wound, the rate of production is one or two order
of magnitude faster [7, 8]. It is also well known that the remodeling process is strongly
affected by the stress and the strain the tissue undergoes, as clearly occurs for bones, teeth,
and muscles [9, 10, 11]. Hence, the relation between the rate of production/degradation of
ECM constituents and the pressure felt by the cells is rather complicated.
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Increased presence of ECM does not characterize only many tumors but was also ob-
served in other pathologies like intima hyperplasia, cardiac, liver, and pulmonary fibrosis,
asthma, colon cancer [12, 13, 14, 6, 15, 16]. The alteration in the ECM composition
can be due to several probably concurring reasons, including increased synthesis of ECM
proteins, decreased activity of MMPs, upregulation of Tissue-specific Inhibitors of Metal-
loProteinases (TIMPs).
The interaction between ECM and cells is also attracting the attention of many research
for other reasons. Indeed, on the one hand cells must adhere properly in order to survive,
a phenomenon called anoikis, as well as be anchored to the ECM to undergo mithosis. On
the other hand, the interaction with the stroma has been argued to be one of the causes
of tumor progression [2, 17, 3, 15, 18].
In this paper we propose a general multiphase mathematical model able to describe the
formation of fibrosis through either excessive production of ECM or underexpression of
MMPs. The model is based on the frameworks deduced in [19, 20], taking also cell-ECM
adhesion into account. In particular, ECM is regarded as a rigid scaffold while the cell
populations (tumor and healthy cells) are assumed to behave similarly to elastic fluids.
More realistic constitutive models, taking cell-cell adhesion into account and comparing
theoretical and experimental results, can be found in [21, 22]. For the sake of conciseness,
we refrain from citing here all papers dealing with multiphase models of tumor growth,
and refer to the recent reviews [23, 24, 25] for more references.
In more detail, Sect. 2 derives and describes the model, which is then studied from
the qualitative point of view in Sect. 3, having in mind the general dependence on the
parameters stemming from biology. Existence, uniqueness, and continuous dependence of
the solution on the initial data is proved in the spatially homogeneous case, and equilibrium
configurations are discussed. These theoretical investigations reveal several interesting
features of the model, for instance the fact that it predicts no other equilibria but the fully
physiological and the fully pathological ones, featuring no tumor cells and no healthy cells,
respectively. The physiological equilibrium turns out to be stable in the manifold with no
tumor cells, but becomes unstable as soon as few tumor cells are present, which trigger the
formation of fibrotic tissue.
2. Multiphase modeling: general picture and particular cases
In the multiphase modeling approach, tumors are regarded as a mixture of several in-
teracting components whose main state variables are the volume ratios, i.e., their percent
amounts within the mixture. With a view to providing a simplified, though still realistic,
description of the system, we confine our attention to two cell populations: tumor cells,
with volume ratio φT , and healthy cells, with volume ratio φH , moving within a remodeling
extracellular matrix with volume ratio φM . Clearly, 0 ≤ φα ≤ 1 for all α = T, H, M .
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Balance equations for the cellular matter. Following [20], we obtain the main governing
equations for the cellular matter by joining the mass balance equation and the correspond-
ing balance of linear momentum (with inertial effects neglected):
(1)
∂φα
∂t
−∇ ·
(
φα
(
φα
φ
− σαM|∇(φΣ(φ))|
)+
KαM∇(φΣ(φ))
)
= Γαφα,
where φ := φT + φH , Γα is the duplication/death rate, and KαM the cell motility tensor
within the matrix. Cells are regarded as elastic balloons forming an isotropic fluid, and are
assumed to feature equal mechanical properties, hence their stress tensor is T = −Σ(φ)I for
a pressure-like function Σ. In addition, the model accounts for the attachment/detachment
of the cells to/from the matrix by means of a stress threshold σαM ≥ 0, which switches
cell velocity on or off according to the magnitude of the actual stress sustained by cells in
interaction with the matrix (see [20] for further details).
In the application to matrix remodeling and fibrosis, we consider that cells duplicate
and die mainly on the basis of the amount of matrix present in the mixture. In general,
also the availability of some nutrients plays a major role, but in the present context we
assume that they are always abundantly supplied to the cells. Specifically, we set
(2) Γα = γα(φM)Hα(ψα − ψ)− δα − δ′αHM (mα − φM),
where ψ := φT + φH + φM is the overall volume ratio occupied by cells and matrix, and
γα(·) is the net growth rate of the cell population α, tempered by the free space rate Hα .
In particular, the Hα ’s are functions bounded between 0 and 1, which vanish on (−∞, 0)
and equal 1 on (α, +∞) (further analytical details in Sect. 3, Assumption 1). Cell growth
is inhibited when the amount of free space locally available is too small (ψ ≥ ψα) with
respect to a threshold ψα ∈ [0, 1]. At the same time, either apoptosis or anoikis can trigger
cell death at rates δα, δ
′
α > 0, respectively, the latter taking place when a too small amount
of ECM (φM ≤ mα) with respect to a given threshold mα ∈ [0, 1] results in an insufficient
number of possible adhesion sites.
Usually γT (·) = γH(·), δT = δH , mT = mH , T = H = M . Instead, a difference between
ψT and ψH , with ψT > ψH , may be related to a smaller sensitivity to contact inhibition
clues by tumor cells [19]. On the whole, we notice that it must be
(3) ΓT (φM , ψ) > ΓH(φM , ψ), ∀ (φM , ψ) ∈ [0, 1]× [0, 1]
which holds if: (i) δ′T < δ
′
H (smaller sensitivity to anoikis by tumor cells), (ii) T > H
(different speed for the switch mechanism, e.g. because of a different uncertainty in the
response to mechanical stimuli), (iii) mT < mH (higher capability from tumor cells to
escape anoikis by surviving a greater lack of adhesion sites).
Matrix remodeling. In general, the ECM is a quite complicated fibrous medium. For the
sake of simplicity, we model it as a rigid scaffold, which makes it unnecessary to detail
its stress tensor because the internal stress is indeterminate due to the rigidity constraint.
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Under this assumption, the evolution equation for the volume ratio φM reads
(4)
∂φM
∂t
= ΓM ,
where ΓM is the source/sink of ECM accounting for remodeling and degradation due to
the motion of the cells within the scaffold. Notice that, in general, φM depends on both
time t and space x, although the latter acts mainly as a parameter in the above differential
equation.
Matrix is globally remodeled by cells and degraded by MMPs, whose concentration per
unit volume is denoted by e = e(t, x):
(5) ΓM =
∑
α=T,H
µα(φM)HM (ψM − ψ)φα − νeφM .
Here, µα is a nonnegative, nonincreasing function (cf. Sect. 3, Assumption 1) repre-
senting the net matrix production rate by the cell population α tempered by the free
space rate HM , and ν > 0 is the degradation rate by the enzymes. As usual, the
latter are not regarded as a constituent of the mixture, but rather as massless macro-
molecules diffusing in the extracellular fluid according to a reaction-diffusion equation:
et = D∆e +
∑
α=T,H piαφα − e/τ , for net production rates piα > 0 and enzyme half-life
τ > 0. Actually, enzyme dynamics is much faster than that involving cell growth and
death, hence it is possible to work under a quasi-stationary approximation. Furthermore
enzyme action is usually very local [26], so that also diffusion can be neglected and fi-
nally e = τ
∑
α=T,H piαφα. Inserting this expression into Eq. (5) and defining να := ντpiα
ultimately yields
ΓM =
∑
α=T,H
(µα(φM)HM (ψM − ψ)− ναφM)φα.
The pathological cases possibly leading to fibrosis are either µT (·) > µH(·) or νT < νH ,
which imply that tumor cells produce either more ECM or less MMPs than healthy cells,
respectively.
3. The spatially homogeneous problem
The spatially homogeneous problem describes the evolution of the system under the main
assumption of absence of spatial variation of the state variables φT , φH , φM . This allows
in particular to describe the equilibria, and the related basins of attraction, as functions
of the parameters of the model.
In the sequel we will be concerned with the following initial value problem:
(6)

dφα
dt
= [γα(φM)Hα(ψα − ψ)− δα − δ′αHM (mα − φM)]φα, α = T, H
dφM
dt
=
∑
α=T,H
(µα(φM)HM (ψM − ψ)− ναφM)φα
φα(0) = φ
0
α ∈ [0, 1], α = T, H, M
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over a time interval (0, T ], T > 0. Some preliminary technical assumptions are in order:
ASSUMPTION 1. For α = T, H, M as appropriate, we assume 0 ≤ ψα, mα ≤ 1,
δα, δ
′
α, να > 0, and in addition that γα, µα : [0, 1]→ R+ are Lipschitz continuous, with γα
nondecreasing, γα(0) = 0, and µα nonincreasing.
Moreover, we assume that the functions Hα : R → [0, 1] are Lipschitz continuous and
vanishing on (−∞, 0].
The monotonicity of γα, µα is dictated by the fact that cell proliferation is fostered by
the presence of ECM, whereas production of new matrix is progressively inhibited by the
accumulation of other matrix. Owing to the properties recalled in Assumption 1, γα, µα,
and Hα satisfy
γα(s) ≤ Lip(γα)s, γα(s) ≤ γα(1), µα(1) ≤ µα(s) ≤ µα(0), ∀ s ∈ [0, 1],(7)
Hα(s− β) ≤ Lip(Hα)|s|, ∀ s ∈ R, β ≥ 0.(8)
The functions Hα may be taken to be mollifications of the Heaviside function, for instance
Hα(s) = 0 if s < 0, Hα(s) = 
−1
α s if 0 ≤ s ≤ α, and Hα(s) = 1 if s > α, or even
smoother.
Let us introduce the space V d := C([0, T ]; Rd) of continuous functions u : [0, T ]→ Rd,
endowed with the∞-norm ‖u‖∞ = maxt∈[0, T ] ‖u(t)‖1. In proving our results we will utilize
d = 3 and d = 4.
Well-posedness. We start by studying existence, uniqueness, and continuous dependence
on the data of the solution φ = (φT , φH , φM) to problem (6). We will then also discuss
its regularity. Since the φα’s are volume ratios, we are interested in nonnegative solutions
such that ψ(t) ≤ 1 for all t ≥ 0.
THEOREM 1 (Existence, uniqueness, and continuous dependence). For each initial da-
tum φ0 ≥ 0 with ‖φ0‖1 ≤ 1, problem (6) admits a unique nonnegative global solution
φ ∈ C([0, +∞); R3) such that ‖φ‖∞ ≤ 1. In addition, if φ1, φ2 are the solutions corre-
sponding to initial data φ01, φ
0
2, then for each T > 0 there exists a constant C = C(T ) > 0
such that
‖φ2 − φ1‖∞ ≤ C(T )‖φ02 − φ01‖1
in the interval [0, T ].
Proof. 1. Let us introduce the function ϕ(t) := 1 − ψ(t) (which, in mixture theory,
identifies the free space available to be filled by some extracellular fluid) and consider
the auxiliary problem given by the set of equations (6) plus ϕ′ = −∑α φ′α, along with
ϕ0 := ϕ(0) = 1−∑α φ0α. Clearly, a triple (φT , φH , φM) is a solution to problem (6) if and
only if the quadruple (φT , φH , φM , ϕ) is a solution to the auxiliary problem.
2. We put the auxiliary problem in compact form as
(9)

dΦ
dt
= J [Φ], t > 0
Φ(0) = Φ0,
6 ANDREA TOSIN AND LUIGI PREZIOSI
where Φ = (φ, ϕ) and J : V 4 → V 4 is given componentwise by the right-hand sides of the
differential equations in (6) plus Jϕ = −
∑
α Jα.
Next we make the substitution Φ(t) = Ψ(t)e−λt, where λ > 0 will be properly selected.
Due to the specific expression of J , the term J [Ψ(t)e−λt] can be given the form I[Ψ](t)e−λt
for a suitable operator I : V 4 → V 4, which allows us to rewrite problem (9) in terms of Ψ
as 
dΨ
dt
= I[Ψ] + λΨ, t > 0
Ψ(0) = Φ0
or, in mild form, as Ψ(t) = Φ0 +
t∫
0
(
I[Ψ](τ) + λΨ(τ)
)
dτ =: G[Ψ](t).
3. Let us look for a mild solution in the following set of admissible functions:
A = {u ∈ V 4 : u(t) ≥ 0, ‖u(t)‖1 = eλt for all t ∈ [0, T ]}.
Notice that Ψ ∈ A amounts in particular to φα(t), ϕ(t) ≥ 0 with
∑
α φα(t) + ϕ(t) = 1 for
all t ∈ [0, T ], thus ∑α φα(t) ≤ 1, which is what the saturation constraint requires on the
volume ratios of the constituents of the mixture.
Any mild solution of Ψ(t) = G[Ψ](t) is a fixed point of the operator G, therefore the
task is to show that G admits a unique fixed point in A.
4. Owing to Assumption 1 and properties (7), (8), if u(t) ≥ 0 then
Gα[u](t) ≥ φ0α + (λ− Cα)
t∫
0
uα(τ) dτ (CT,H = δT,H + δ
′
T,H , CM = νT + νH),
Gϕ[u](t) ≥ ϕ0 +
(
λ−
∑
α=T,H
(γα(1)Lip(Hα) + µα(0)Lip(HM ))
) t∫
0
uϕ(τ) dτ,
hence we can choose λ > 0 so large that G[u](t) ≥ 0 as well. If in addition ‖u(t)‖1 = eλt
then, using Iϕ = −
∑
α Iα, we discover ‖G[u](t)‖1 = eλt. In conclusion, u ∈ A implies
G[u] ∈ A, i.e., G maps A into itself.
5. Take now u, v ∈ A and observe that
‖G[u](t)−G[v](t)‖1 ≤
t∫
0
(‖I[u](τ)− I[v](τ)‖1 + λ‖u(τ)− v(τ)‖1) dτ.
Lipschitz continuity of γα, µα, Hα along with Hα(s) ≤ 1 and properties (7), (8) imply
that there exists C > 0, independent of T , such that |Iα[u](t)−Iα[v](t)| ≤ C‖u(t)−v(t)‖1
each α = T, H, M . Since Iϕ = −
∑
α Iα, an analogous relationship holds true also for
Iϕ, hence finally ‖G[u] − G[v]‖∞ ≤ T (C + λ)‖u − v‖∞, which proves that G is Lipschitz
continuous on A.
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6. From the above calculations we see that we can choose T > 0 so small that G
be a contraction on A. Since A is a closed subset of V 4, Banach Fixed Point Theorem
asserts that G has a unique fixed point Ψ ∈ A. Therefore, the auxiliary problem (9)
admits a unique nonnegative local solution Φ ∈ V 4 such that ‖Φ(t)‖1 = 1. The three
first components of Φ form the unique nonnegative solution φ ∈ V 3 to problem (6) with
‖φ(t)‖1 ≤ 1.
Next, taking φ(T ) as new initial condition and observing that it matches all the hypothe-
ses satisfied by φ0, we uniquely prolong φ over the time interval [T, 2T ] in such a way that
φ(t) ≥ 0 and ‖φ(t)‖1 ≤ 1 all t ∈ [0, 2T ]. Proceeding inductively, we ultimately end up
with a unique nonnegative global solution φ ∈ C([0, +∞); R3), for which the estimate
‖φ‖∞ ≤ 1 easily follows from ‖φ(t)‖1 ≤ 1 all t ≥ 0.
7. Let now Ψ1, Ψ2 ∈ A be the two mild solutions corresponding to initial data Φ01, Φ02.
Using the previous estimates we discover
‖Ψ2(t)−Ψ1(t)‖1 ≤ ‖Φ02 −Φ01‖1 + (C + λ)
t∫
0
‖Ψ2(τ)−Ψ1(τ)‖1 dτ,
whence, invoking Gronwall’s inequality,
‖Ψ2(t)−Ψ1(t)‖1 ≤
[
1 + (C + λ)te(C+λ)t
] ‖Φ02 −Φ01‖1.
Returning to Φ1, Φ2 and observing that ‖Φ02 − Φ01‖1 ≤ 2‖φ02 − φ01‖1 we finally get the
desired estimate of continuous dependence, after taking the maximum of both sides for
t ∈ [0, T ]. 
THEOREM 2 (Regularity). If the functions γα, µα, Hα are of class C
k on [0, 1] then
the solution φ is of class Ck+1 on [0, +∞).
Proof. According to Theorem 1, the φα’s are continuous on [0, +∞), therefore the right-
hand sides of the differential equations in (6) define continuous functions on [0, +∞). It
follows that the φ′α’s are continuous as well, i.e., the solution φ is actually C
1 on [0, +∞). If
γα, µα, Hα are of class C
k then, by differentiating the ODEs in (6) k times, this reasoning
can be applied inductively to discover φ ∈ Ck+1([0, +∞); R3). 
Stability of the equilibrium configurations. Next we study the equilibria of model (6). It
is immediately seen that φT = φH = 0 gives rise to an equilibrium solution for any
φM ∈ [0, 1], corresponding to that all cells have died leaving some ECM. In order to
investigate nontrivial equilibrium configurations, we proceed by considering first the two
important sub-cases in which either φT = 0 or φH = 0 but φT , φH do not vanish at the
same time. The former will be referred to as the fully physiological case, the latter as the
fully pathological one. In the following, φα will be the nonzero volume ratio for either
α = T or α = H, meaning that the other one is identically zero. For the sake of simplicity,
let us fix ψM = 1 and examine the case φα + φM ≤ 1− η for some arbitrarily small η > 0,
in such a way that, choosing M < η, we have the simplification HM (ψM − φα − φM) = 1.
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Figure 1. Left: phase portrait in the fully physiological or pathological
case. Right: phase portrait for the full model.
Suppose that the function µα(s) − ναs has exactly one zero, say s = Mα. Since, for
physiological reasons, we further must have µα(ψα) < ναψα, it follows Mα ∈ (0, ψα). In
this case, there is one nontrivial equilibrium given by
(10) φM = Mα, φα = ψα −Mα −H−1α
(
δα + δ
′
αHM (mα −Mα)
γα(Mα)
)
,
which is readily checked to be stable. Notice that the function H−1α (s) is well defined for
s ∈ (0, 1).
The trivial equilibrium with also φα = 0 can be reached basically in two situations. The
first one is when φM is initially too small, so that the growth rate of the cells is lower than
the apoptotic rate and anoikis occurs. This corresponds to initial conditions located in the
lower-left corner of the phase portrait illustrated in Fig. 1, left. The equation φα = φα(φM)
of the curve delimiting this basin of attraction in the phase space is obtained by integrating
(11)
dφα
dφM
=
γα(φM)Hα(ψα − φα − φM)− δα − δ′αHM (mα − φM)
µα(φM)− ναφM
with the condition φα(φ
?
Mα) = 0, φ
?
Mα ∈ (0, 1) being the smaller root of the equation
Γα(φM) = 0 with φT = φH = 0, cf. Eq. (2), characterized by Γ
′
α(φ
?
Mα) > 0. This region
does not exist if φ?Mα < 0.
The second case is when φM is initially too large, namely the ECM is overly dense and
cells are so compressed that the growth rate is again lower than the apoptotic rate because
Hα(ψα − φα − φM) ≈ 0. This corresponds to initial conditions located in the lower-right
corner of the phase portrait depicted in Fig. 1, left. The curve delimiting the basin of
attraction is again obtained by integrating Eq. (11), now with the condition φα(φ
??
Mα) = 0,
φ??Mα ∈ (0, 1) being the larger root of the equation Γα(φM) = 0 with φT = φH = 0, so that
φ?Mα ≤ φ??Mα. In this case Γ′α(φ??Mα) < 0. The region does not exist if φ??Mα > 1.
In order to get the complete picture, we further have to investigate whether a nontrivial
equilibrium with φT , φH > 0 may exist. For this, we recall that the duplication/death rates
Γα are constructed so as to match the biological requirement ΓT (φM , ψ) > ΓH(φM , ψ) for
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Figure 2. Left: formation of normal tissue in the physiological case. Right:
formation of hyperplastic fibrotic tissue due to a small initial amount of
tumor cells.
all (φM , ψ) ∈ [0, 1]× [0, 1], cf. Eq. (3). As a consequence, we see that it is impossible for
the right-hand sides of the two first equations of problem (6) to vanish simultaneously at
an equilibrium point (φT , φH , φM) with φT , φH 6= 0, for this would imply that there exist
φM ∈ [0, 1] and ψ ∈ (0, 1] such that Γα(φM , ψ) = 0 for both α = T, H, which contradicts
the above-mentioned Eq. (3).
Hence, the only possible equilibria of the system are those arising in the fully physiolog-
ical or pathological situation. In addition, condition (3) makes the nontrivial physiological
equilibrium unstable and the nontrivial pathological one stable, as it can be realized from
the three-dimensional phase portrait shown in Fig. 1, right.
Figure 2 (left) shows an example of a temporal evolution of the system giving rise to the
formation of normal tissue in the fully physiological case. The initial death of healthy cells
is due to anoikis, indeed cells are seeded in an environment completely deprived of ECM,
that they have to build fast enough. The decrease stops as soon as the amount of ECM
produced is such that γH(φM)HH (ψH −ψ) ≥ δH + δ′HHM (mH −φM), then the number of
cells starts increasing, eventually leading to the stationary solution predicted by Eq. (10)
for α = H. Conversely, if the initial amount of cells is insufficient to produce ECM rapidly
enough then the entire population will die.
Figure 2 (right) gives instead an example of a complete temporal history ending with the
formation of hyperplastic and fibrotic tissue. Despite the initial conditions φ0H , φ
0
M coincide
with the equilibrium values reached after the formation of normal tissue, the presence of a
small amount of tumor cells (φ0T > 0) changes dramatically the outcome of the evolution,
leading to a full depletion of healthy cells. This evolution can be duly compared with that
shown in Fig. 3, which refers to the simulation of the full spatial and temporal model in
one space dimension, cf. Eqs. (1), (4). Starting from the same initial conditions as in the
spatially homogeneous case, the presence of a small amount of tumor cells at the beginning
generates a traveling wave, which progressively depletes healthy cells and produces further
fibrotic matrix while invading the normal tissue.
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Figure 3. Traveling wave solutions for φH (blue), φT (red), φM (green) in
the full spatial and temporal evolution.
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